Advate
Product Images NDC 0944-2943

Product Visual Gallery

This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Advate (NDC 0944-2943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Advate 01)

An instructional illustration showing a hand holding an ADVATE injection device by Baxter Healthcare Corporation. The image highlights the grip and positioning of the device, which features a blue button and a transparent body.*

FDA Label Image

Figure B (Advate 02)

Instructional illustration showing hand positioning and pressing down on the top of an ADVATE drug delivery device, demonstrating how to operate the device mechanism.*

FDA Label Image

Figure C (Advate 03)

An instructional illustration showing a hand holding the ADVATE auto-injector device. The image demonstrates a twisting motion indicated by a circular arrow, likely related to preparing the device for use. The device is white and blue with a transparent section.*

FDA Label Image

Figure D (Advate 04)

An instructional diagram showing two steps for assembling or preparing a syringe device. Step 1 illustrates placing a cap or component onto the top of the syringe. Step 2 indicates rotating or twisting the syringe barrel, likely to secure or activate the device. The diagram is simple and schematic, with arrows guiding the sequence.*

FDA Label Image

Figure E (Advate 05)

An instructional diagram showing the connection of a syringe to an ADVATE device, demonstrating the proper method to attach the syringe for medication preparation or administration by Baxter Healthcare Corporation.*

FDA Label Image

Image (Advate 06)

FDA Label Image

Image (Advate 07)

FDA Label Image

Image (Advate 08)

FDA Label Image

Image (Advate 09)

FDA Label Image

Image (Advate 10)

FDA Label Image

Image (Advate 11)

FDA Label Image

Image (Advate 12)

FDA Label Image

Figure (Advate 13)

An instructional illustration showing a hand holding an ADVATE drug product device, demonstrating proper grip and handling for administration. The device is clear with blue accents and appears designed for easy administration of medication.*

FDA Label Image

Figure (Advate 14)

An instructional illustration depicting two hands using a medical device with a blue button, with a downward arrow indicating a pressing or activating action. The image likely shows how to operate or prepare the device, associated with ADVATE by Baxter Healthcare Corporation.*

FDA Label Image

Figure (Advate 15)

An instructional diagram showing a hand holding the ADVATE prefilled syringe device. The image demonstrates rotating the blue safety guard or cap at the syringe tip in the direction of the arrow, indicating preparation for injection.*

FDA Label Image

Figure (Advate 16)

An instructional diagram showing a syringe being connected to a vial adapter, labeled with step numbers indicating to remove the blue cap from the vial adapter (step 1) and to rotate the syringe for attachment (step 2). The illustration is related to preparing or connecting ADVATE injection components.*

FDA Label Image

Figure (Advate 17)

An instructional illustration showing a syringe connected to a vial adapter. The image indicates the process of attaching or drawing medication, highlighted by a black arrow pointing to the right. This likely demonstrates preparation or administration steps related to ADVATE.*

FDA Label Image

Figure (Advate 18)

Illustration showing a gloved hand applying a small adhesive patch to the inner forearm of a patient, with a tourniquet secured around the upper arm.*

FDA Label Image

Figure (Advate 19)

An instructional illustration showing a gloved hand holding a syringe connected to an intravenous (IV) catheter inserted into a patient's forearm vein, demonstrating the procedure for IV administration likely related to the ADVATE medication.*

FDA Label Image

Advate 20

ADVATE [Antihemophilic Factor (Recombinant)] label for single-use vial, 2 mL volume. It states intravenous administration only, preassembled in BAXJECT III system, with instructions not to open until use and to avoid use if packaging is damaged. The product contains no plasma or albumin. Labeler is Baxter Healthcare Corporation, co-branded with Shire.*

FDA Label Image

Advate 21

ADVATE Antiheamophilic Factor (Recombinant) packaging label for lyophilized powder for intravenous administration. The label indicates ADVATE and diluent are preassembled in the BAXJECT III system. The package includes multiple panels detailing product stabilization ingredients, storage instructions, and trademark information. The labeler is Baxter Healthcare Corporation, with branding noted from Shire. The product is single-use only and does not contain plasma/albumin.*

FDA Label Image

Advate 22

An illustration diagram for ADVATE (Antihemophilic Factor Recombinant) shows instructions for intravenous administration using the BAXJECT III system. The steps include pressing, swirling to mix, and flipping & withdrawing the solution. The label states the product is for intravenous use only, is supplied preassembled with diluent, and contains no plasma or albumin. The labeler is indicated as Baxter Healthcare Corporation (Shire).*

FDA Label Image

Advate 23

ADVATE [Antihemophilic Factor (Recombinant)] 2 mL single-use vial label by Baxter Healthcare Corporation. The label specifies intravenous administration only and states the product is preassembled in BAXJECT III system. It includes warnings not to open until use and to avoid use if packaging is damaged. The label also notes the product does not contain plasma or albumin and is Rx only.*

FDA Label Image

Advate 24

ADVATE Antiinhemophilic Factor (Recombinant) packaging label by Baxter Healthcare Corporation. The label indicates lyophilized powder for reconstitution and includes a preassembled BAXJECT III system with 2 mL sterile water for injection. Storage instructions, stabilization agents, and manufacturer information from Baxalta US Inc. are visible, along with regulatory details and usage notes.*

FDA Label Image

Advate 25

An instruction panel for ADVATE (Antihemophilic Factor [Recombinant]) by Baxter Healthcare Corporation. It depicts three step-by-step illustrations showing how to use the BAXJECT III system for intravenous administration: press, swirl, and flip & withdraw. Text notes include directions to see the package insert and that the product does not contain plasma or albumin.*

FDA Label Image

Advate 26

ADVATE label for antihemophilic factor (recombinant) manufactured by Baxter Healthcare Corporation. The label indicates single use only, for intravenous administration with preassembled diluent in the BAXJECT III system, and contains 2 mL. Warnings include not opening until use time and not using if packaging is opened or damaged. The label notes the product does not contain plasma or albumin.*

FDA Label Image

Advate 27

ADVATE [Antihemophilic Factor (Recombinant)] carton label with details for intravenous administration. The label highlights lyophilized powder for reconstitution and includes a small vial image. Manufactured by Baxter Healthcare Corporation, it notes single-use only, no plasma/albumin content, and a 2 mL potency volume. Storage and handling instructions along with trademark and patent information are also visible.*

FDA Label Image

Advate 28

This label panel for ADVATE [Antihemophilic Factor (Recombinant)] by Baxter Healthcare Corporation includes administration instructions and warnings. It states the product is for intravenous use only, preassembled in a BAXJECT III system and advises users to see the package insert for directions. The panel also notes the product does not contain plasma or albumin. Diagrams show pressing, swirling, and withdrawing steps for use.*

FDA Label Image

Advate 29

ADVATE label for antihemophilic factor (recombinant) by Baxter Healthcare Corporation. The label indicates the product is for intravenous administration only, comes as a 2 mL solution preassembled in the BAXJECT III system, and is single use. The label includes a lot number, expiration, and IU sections for dose tracking, and notes the product does not contain plasma or albumin.*

FDA Label Image

Advate 30

ADVATE Antihemophilic Factor (Recombinant) packaging label showing a lyophilized powder for reconstitution and intravenous administration only. The carton indicates a 2 mL package with ADVATE and diluent preassembled in the BAXJECT III system. The label features the Shire logo and includes storage and composition information, trademarks, patent link, and barcode.*

FDA Label Image

Advate 31

This is a drug facts panel for ADVATE [Antihemophilic Factor (Recombinant)], provided by Baxter Healthcare Corporation. It indicates intravenous use only and prescription status, mentions ADVATE and diluent preassembled in the BAXJECT III system, and notes the product does not contain plasma or albumin. It includes instructions to see the package insert and diagrams showing pressing, swirling, and withdrawing steps for administration.*

FDA Label Image

Advate 32

ADVATE [Antihemophilic Factor (Recombinant)] vial label for intravenous administration. The label indicates a 5 mL single-use vial with no plasma or albumin content. Instructions include using the product only if packaging is intact and noting it is preassembled in the BAXJECT III system. Labeler is Baxter Healthcare Corporation, and the Shire logo appears.*

FDA Label Image

Advate 33

ADVATE Antihemmophilic Factor (Recombinant) packaging label by Baxter Healthcare Corporation, featuring text indicating lyophilized powder for reconstitution and a 5 mL diluent preassembled in BAXJECT III system. The label includes storage instructions, stabilizing agent information, trademark and patent details, and manufacturer location in Lexington, MA, USA. The design shows the ADVATE logo and Shire branding with a depiction of the product vial and diluent system.*

FDA Label Image

Advate 34

ADVATE Antihemophilic Factor (Recombinant) label showing instructions for intravenous administration only. The label includes visual step-by-step directions to press, swirl, flip and withdraw using a BAXJECT III system. The product does not contain plasma/albumin and is Rx only. The label also shows logos for Shire and Baxter Healthcare Corporation along with lot, expiration, and other identifying codes.*

FDA Label Image

Advate 35

ADVATE label for Antihemophilic Factor (Recombinant) by Baxter Healthcare Corporation. The label indicates it is for intravenous administration only and preassembled in the BAXJECT III system. It states single use only with a volume of 5 mL. The label includes space for IU, lot, and expiration date, with a note stating "NO COAT" and cautions about packaging integrity. The Shire logo is present as well.*

FDA Label Image

Advate 36

ADVATE Antihemmophilic Factor (Recombinant) packaging label includes product name, dosage form as lyophilized powder for intravenous administration, and prefilled diluent in BAXJECT III system. It specifies single-use 5 mL volume, no plasma/albumin content, stabilizing agents, storage instructions between 36° to 46°F (2°-8°C) or room temperature up to 86°F (30°C) for 6 months, and manufacturing by Baxter Healthcare Corporation under Shire trademarks. Barcodes and regulatory notices are also present.*

FDA Label Image

Advate 37

ADVATE [Antihemophilic Factor (Recombinant)] label highlights intravenous administration only, preassembled in the BAXJECT III system. Instructions include visual guides for pressing, swirling, and withdrawing steps during preparation. The label notes the product contains no plasma or albumin and displays the Shire logo, lot, and expiration information fields.*

FDA Label Image

Advate 38

ADVATE [Antihemophilic Factor (Recombinant)] packaging label from Baxter Healthcare Corporation. Label indicates single use only and intravenous administration. It states that ADVATE and diluent are preassembled in BAXJECT III system and provides warnings not to open until use or if packaging is damaged. The label includes volume of 5 mL, NDC 0944-3047-11, and the Shire logo. There are spaces for IU, batch lot, and expiration date. The label also specifies the product does not contain plasma/albumin.*

FDA Label Image

Advate 39

ADVATE [Antihemophilic Factor (Recombinant)] packaging label showing product as lyophilized powder for intravenous administration. The label indicates 5 mL of solution preassembled in BAXJECT III system. Manufactured by Baxter Healthcare Corporation (Shire). Includes storage instructions, non-presence of plasma/albumin, and stabilizing agents listed in the product.*

FDA Label Image

Advate 40

This image shows a drug information label for ADVATE (Antihemophilic Factor Recombinant), intended for intravenous administration only and available by prescription. It includes preparation instructions involving pressing, swirling, and flipping to withdraw the medication, which is preassembled in the BAXJECT III system. Additional details note that the product does not contain plasma or albumin. The label also features Shire branding and indicates lot and expiration information is absent or replaced by the text 'NO COAT.'*

FDA Label Image

Advate 41

A partial label of ADVATE antihemophilic factor (recombinant) showing branding from Shire and a space for the lot number, with the number 0742475 visible. The label is associated with Baxter Healthcare Corporation.*

FDA Label Image

Advate 42

Label for Sterile Water for Injection, showing a lot number field and naming Siegfried Hameln GmbH as the manufacturer. The label is primarily blue and white with some pink outlining.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.